Consider Tina’s Wish as your beneficiary organization for an upcoming athletic fundraising event. Examples include: marathons, half marathons, boxing matches, bike rides, and walk-a-thons.
Check out the Van Cortlandt Summer Series 5K and other athletic event partners.
Many organizations and companies match their employees’ charitable giving. Contact your company’s human resources department or community affairs department for more information, or check out the Double the Donation tool here to check if your employer participates in corporate matching to double your impact.
In lieu of a traditional card, honor a loved one with a donation in support of early detection ovarian cancer research and Tina’s Wish will send them a card or e-card. Click here to send a birthday or tribute card.
Ronny Drapkin, MD, PhD, is the Director of the Ovarian Cancer Research Center at the University of Pennsylvania where he also serves as the Director of Gynecologic Cancer Research at The Basser Center for BRCA and the Director of the Translational Center of Excellence for Ovarian Cancer at the PennMedicine Abramson Cancer Center.
Dr. Drapkin received his undergraduate degree from Brandeis University, his PhD from the Rutgers University Graduate School of Biomedical Sciences, and his MD from the Rutgers University Robert Wood Johnson Medical School. He completed his residency in Anatomic Pathology at the Brigham and Women’s Hospital and his postdoctoral fellowship at the Dana-Farber Cancer Institute.
The Drapkin laboratory focuses on understanding the genetic, molecular, and physiological factors that drive the development of ovarian cancer. Dr. Drapkin’s work led to the appreciation that the fallopian tube is likely the site of origin for a majority of high-grade serous ovarian carcinomas. This finding was a paradigm shift in the field and motivated his lab to develop novel experimental model systems to study the fallopian tube and determine what makes it susceptible to becoming a cancer.
Dr. Drapkin is currently a Tina’s Wish Individual Investigator and Consortium Grant Recipient for 2019-2021. Read more about his work to discover genetic and protein biomarkers indicative of ovarian cancer here, and his work to develop early-detection methods here.
Help Tina’s Wish fund research to find an early effective screen for ovarian cancer by donating today.
If you wish to donate online, please click here.
To pay by check, please make the check payable to ‘The Honorable Tina Brozman Foundation, Inc.’ and send it to:
The Honorable Tina Brozman Foundation, Inc.
P.O. Box 7590
New York, New York 10116
Jeffery “Jeff” Stegenga is a Managing Director with Alvarez & Marsal, and leads its North American Commercial Restructuring practice out of Dallas. Jeff is nationally regarded as a specialist in Chapter 11 restructurings (pre-packaged/pre-arranged/traditional) and distressed financial consulting, focusing primarily on large, company side engagements.
Jeff earned a BS in accountancy from Arizona State University. He is a Certified Insolvency and Reorganization Advisor (CIRA), a member of the Turnaround Management Association (TMA) and a fellow in the American College of Bankruptcy.
A&M has been a Tina’s Wish Benefit Committee sponsor since 2010 and Jeff served as Benefit co-chair in 2019.
